Skip to main content

Month: September 2025

Royal Road and Rio2 Announce Share Acquisition by Rio2

TORONTO, Sept. 29, 2025 (GLOBE NEWSWIRE) — Royal Road Minerals Limited (TSXV: RYR; OTCQB: RRDMF) (“Royal Road” or the “Company”) and Rio2 Limited (TSX: RIO; OTCQX: RIOFF; BVL: RIO) (“Rio2”) are pleased to jointly announce that Rio2 has acquired 39,855,000 ordinary shares of Royal Road (“Shares”) representing approximately 15.0% of Royal Road’s issued and outstanding Shares and has become an “insider” of the Company under applicable securities laws and the policies of the TSX Venture Exchange (“TSXV”). The acquisition formed part of a block trade on the TSX Venture Exchange, transferring the entire shareholding previously held by a single investor to Rio2 and other institutional investors known to both parties. “We are genuinely delighted to welcome Rio2, under the leadership of Alex Black and Andrew Cox, as our new shareholders...

Continue reading

Asante Announces Start of Bibiani Sulphide Plant Operation

VANCOUVER, British Columbia, Sept. 29, 2025 (GLOBE NEWSWIRE) — Asante Gold Corporation (TSXV:ASE | GSE:ASG OTCQX:ASGOF) (“Asante” or the “Company”), an emerging mid-tier gold producer, is pleased to provide an update on progress made on its sulphide plant at the Bibiani Gold Mine (“Bibiani Mine” and “Bibiani”), in the republic of Ghana.   Recent Highlights:Health and safety: Lost Time Incident Frequency Rate of 0.00, and Total Recordable Incident Frequency Rate of 0.00 for year-to-date 2025 Project Cost: Total spent to date of US$32M versus US$32M budgeted (pre-tax) Status: Construction and commissioning are complete12 h/d operation to process Bibiani ore started on September 27, 2025 24 h/d operation expected to start on September 30, 2025 and optimization to achieve +85% gold recovery will progress through October 2025Bibiani...

Continue reading

Novartis announces commencement of tender offer to acquire Tourmaline Bio

Basel, September 29, 2025 – Novartis today announced that Torino Merger Sub Inc., a Delaware corporation and an indirect wholly owned subsidiary of Novartis (“Purchaser”), has commenced a tender offer to acquire all of the outstanding shares of common stock, par value $0.0001 per share (the “Shares”), of Tourmaline Bio, Inc., a Delaware corporation (“Tourmaline”), at a price of $48 per Share, in cash, without interest and subject to any applicable withholding. Such offer is being made upon the terms and subject to the conditions set forth in the Offer to Purchase, dated September 29, 2025, and the related Letter of Transmittal (together, the “Offer”) and pursuant to the terms of the previously announced Agreement and Plan of Merger, dated as of September 8, 2025 (the “Merger Agreement”), among Novartis, Purchaser and Tourmaline.  The...

Continue reading

Amplify ETFs Declares September Income Distributions for its Income ETFs

CHICAGO, Sept. 29, 2025 (GLOBE NEWSWIRE) — Amplify ETFs announces September income distributions for its income ETFs.ETF Name Ticker Amount per Share Ex-Date Record Date Payable DateAmplify Bitcoin Max Income Covered Call ETF BAGY $1.53000 9/29/25 9/29/25 9/30/25Amplify Bitcoin 2% Monthly Option Income ETF BITY $1.09700 9/29/25 9/29/25 9/30/25Amplify SILJ Covered Call ETF SLJY $0.48366 9/29/25 9/29/25 9/30/25Amplify Samsung SOFR ETF SOFR $0.36238 9/29/25 9/29/25 9/30/25Amplify CWP Growth & Income ETF QDVO $0.29060 9/29/25 9/29/25 9/30/25Amplify COWS Covered Call ETF HCOW $0.24160 9/29/25 9/29/25 9/30/25Amplify Bloomberg U.S. Treasury 12% Premium Income ETF TLTP $0.22740 9/29/25 9/29/25 9/30/25Amplify CWP International Enhanced Dividend Income ETF IDVO $0.18550 9/29/25 9/29/25 9/30/25Amplify CWP...

Continue reading

Costamare Bulkers Holdings Limited Announces Strategic Cooperation Agreement with Cargill International SA

MONACO, Sept. 29, 2025 (GLOBE NEWSWIRE) — Costamare Bulkers Holdings Limited (“Costamare Bulkers” or the “Company”) (NYSE: CMDB) announced today that it has signed a Strategic Cooperation Agreement (the “Agreement”) with Cargill International S.A. (“Cargill”). Under the Agreement, the Company has agreed to:Transfer to Cargill the majority of its trading book comprising of chartered-in vessels, cargo transportation commitments as well as derivative positions; Charter to Cargill four Supramax vessels for a period of four to six months; Enter into a bunkering services agreement with Seascale Energy (a joint venture between Cargill and Hafnia), covering the owned and operating fleet; Enter into an agreement in respect of decarbonisation and vessel efficiency strategies and implementing decarbonisation projects; Explore opportunities...

Continue reading

Dogwood Therapeutics Secures Exclusive Worldwide, Royalty Free License to Develop and Commercialize SP16 as a Treatment for Cancer Related Pain in an All-Stock Transaction Underscoring the Company’s Dedication to Improving the Lives of Cancer Patients

-A first-in-class LRP1 agonist, SP16 phase 1b Chemotherapy Induced Neuropathy (CIPN) Study fully funded by the National Cancer Institute, with projected patient enrollment beginning in the first half of 2026- –SP16 has demonstrated both anti-inflammatory and neural repair activity that has the potential to treat CIPN, synergistically complementing Halneuron®, the Company’s late stage NaV1.7 inhibitor, which has demonstrated significant pain reduction in previous Phase 2 studies- -Webcast today, September 29, 2025, at 8:30 a.m. Eastern Time- ATLANTA, Sept. 29, 2025 (GLOBE NEWSWIRE) — Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (“Dogwood” or the “Company”), a clinical-stage biotechnology company developing new medicines to treat pain and neuropathy, today announced that in an all-stock transaction, it has secured a royalty free,...

Continue reading

NOVONIX Achieves Critical Operational Milestone

Commercial-grade sampleFirst mass production, industrial-grade sample of synthetic graphite.NOVONIX Riverside FacilityNOVONIX’s Riverside facility in Chattanooga, Tennessee, poised to become the first large-scale production site dedicated to high-performance synthetic graphite for the battery, defense, and industrial sectors in North America.CHATTANOOGA, Tenn., Sept. 29, 2025 (GLOBE NEWSWIRE) — NOVONIX Limited (NASDAQ: NVX, ASX: NVX) (“NOVONIX” or the “Company”), a leading battery materials and technology company, announced today the delivery of its first mass production, commercial-grade sample of synthetic graphite for industrial applications to one of North America’s largest value-added carbon processors with a global market reach. “We’re pleased to have hit this significant manufacturing milestone,”...

Continue reading

Enlight Secures Nearly $340 Million in Tax Equity Partnerships for Roadrunner Solar and Energy Storage Project

Roadrunner signs two separate tax equity partnerships: J.P. Morgan for solar, and M&T Bank together with First Citizens Bank, for energy storage Roadrunner, a 290 MW solar and 940 MWh storage project in Arizona, has initiated production of test energy and is expected to reach full COD by the end of 2025 Enlight strengthens its U.S. growth strategy, collaborating with new financing partners to support a robust project pipeline across leading power markets TEL AVIV, Israel, Sept. 29, 2025 (GLOBE NEWSWIRE) — Enlight Renewable Energy (TASE&NASDAQ: ENLT), a leading global renewable energy company, announced today that its U.S. subsidiary Clēnera Holdings has closed two tax equity partnership agreements for the Roadrunner Solar and Energy Storage Project, located near Tucson, Arizona. The first agreement, with J.P. Morgan Chase...

Continue reading

MannKind Appoints Dr. Ajay Ahuja as Executive Vice President and Chief Medical Officer

MannKind CMOMannKind appoints Dr. Ajay Ahuja as EVP, Chief Medical OfficerWESTLAKE VILLAGE, Calif., Sept. 29, 2025 (GLOBE NEWSWIRE) — MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of innovative inhaled therapeutic products and devices for patients with endocrine and orphan lung diseases, today announced the appointment of Ajay Ahuja, MD, MBA, as Chief Medical Officer, effective today. Dr. Ahuja will report directly to Michael Castagna, PharmD, Chief Executive Officer, and will serve on the company’s executive leadership team. “Ajay’s deep expertise in medical affairs, clinical development, and global strategy—combined with his background as a practicing physician—will be instrumental as we continue to advance our pipeline and expand our impact in endocrine and orphan lung...

Continue reading

USA Rare Earth Accelerates Mine-to-Magnet Strategy with the Transformative Acquisition of Less Common Metals (LCM)

Establishes USAR as the Leading Scaled Rare Earth Metal and Alloy Manufacturer Outside of China with Leadership in Samarium, Samarium Cobalt and Neodymium Praseodymium Metals and Alloys Secures Critical Link in USAR’s Supply Chain by Providing Rare Earth Metal and Strip Cast Alloy Capability and Ability to Make Metal from Recycled Rare Earth Oxides Creates Unique Competitive Advantage and Accelerates USAR’s Revenue Generation Ability Significant Revenue Synergies Provided by Access to an Expanded Global Customer Base, Important Supply Chain Relationships and Allied Governments $125 Million Common Stock Equity Investment from Existing Shareholder Provides Capital to Expedite Growth Plans USAR to Host Conference Call at 8:30am ET STILLWATER, Okla., Sept. 29, 2025 (GLOBE NEWSWIRE) — USA Rare Earth, Inc. (Nasdaq: USAR) (USAR or the...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.